Evidence map›Paper›PMID 35486333›Full record

SynthesisNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2022

[18F]FDG brain PET and clinical symptoms in different autoantibodies of autoimmune encephalitis: a systematic review.

Fardin Nabizadeh, Elham Ramezannezhad, Alireza Sardaripour, Seyed Ali Seyedi, Negin Salehi, Nasim Rezaeimanesh, Abdorreza Naser Moghadasi

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. The Role of [Diagnostics (Basel, Switzerland) · 2025
    Review
  3. Article
  4. The clinical and predictive value ofCNS neuroscience & therapeutics · 2024
    Article
  5. Article
  6. Review
  7. Quantitative brainAnnals of clinical and translational neurology · 2024
    Article
  8. Typical metabolic pattern ofBMC neuroscience · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Fardin NabizadehNeuroscience Research Group (NRG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Elham RamezannezhadSchool of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Alireza SardaripourMultiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Seyed Ali SeyediSchool of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Negin SalehiSchool of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Nasim RezaeimaneshMultiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Abdorreza Naser MoghadasiMultiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. abdorrezamoghadasi@gmail.com.ORCID http://orcid.org/0000-0002-8598-0911
Isfahan University of Medical Sciences · IRTehran University of Medical Sciences · IRIran University of Medical Sciences · IRShahid Beheshti University · IRShiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAutoimmune encephalitis (AE) is caused by the antibodies that target receptors and intracellular or surface proteins. To achieve the appropriate therapeutic results, early and proper diagnosis is still the most important issue. In this review, we provide an overview of FDG-PET imaging findings in AE patients and possible relation to different subtypes and clinical features.

methodsPubMed, Web of Science, and Scopus were searched in August 2021 using a predefined search strategy.

resultsAfter two-step reviewing, 22 studies with a total of 332 participants were entered into our qualitative synthesis. In anti-NMDAR encephalitis, decreased activity in the occipital lobe was present, in addition, to an increase in frontal, parietal, and specifically medial temporal activity. Anti-VGKC patients showed altered metabolism in cortical and subcortical regions such as striata and cerebellum. Abnormal metabolism in patients with anti-LGI1 has been reported in diverse areas of the brain including medial temporal, hippocampus, cerebellum, and basal ganglia all of which had hypermetabolism. Hypometabolism in parietal, frontal, occipital lobes, temporal, frontal, and hippocampus was observed in AE patients with anti-GAD antibodies.

conclusionOur results indicate huge diversity in metabolic patterns among different AE subtypes and it is hard to draw a firm conclusion. Moreover, the timing of imaging, seizures, and acute treatments can alter the PET patterns strongly. Further prospective investigations with specific inclusion and exclusion criteria should be carried out to identify the metabolic defect in different AE subtypes.

Indexed as

Anti-N-Methyl-D-Aspartate Receptor EncephalitisFluorodeoxyglucose F18AutoantibodiesBrainEncephalitisHashimoto DiseaseHumansMagnetic Resonance ImagingPositron-Emission TomographyAutoantibodiesFluorodeoxyglucose F18Anti-LGI1Anti-NMDAR encephalitisAnti-VGKCAutoimmune encephalitisFDG-PET

Identifiers

PMID35486333
OpenAlexW4225120323

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.